KRISTIN SCOGGINS: Open Payments
NPI 1114789781 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,360 in 131 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,358 · 2025 $2,360
Food & beverage: $2,360
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $458 |
| Mallinckrodt Hospital Products Inc. | 17 | $410 |
| Verona Pharma, Inc. | 25 | $269 |
| GlaxoSmithKline, LLC. | 12 | $225 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $205 |
| Merck Sharp & Dohme LLC | 8 | $170 |
| GENZYME CORPORATION | 9 | $170 |
| Viatris Specialty LLC | 10 | $143 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| United Therapeutics Corporation | 3 | $51 |
Products named: ACTHAR, Ohtuvayre, DUPIXENT, BREZTRI, NUCALA, YUPELRI, FASENRA, OFEV.
Industry payments across MS — which companies pay providers there.
